Package 42291-922-01

Brand: theophylline

Generic: theophylline
NDC Package

Package Facts

Identity

Package NDC 42291-922-01
Digits Only 4229192201
Product NDC 42291-922
Description

100 TABLET, EXTENDED RELEASE in 1 BOTTLE (42291-922-01)

Marketing

Marketing Status
Marketed Since 2023-04-13
Brand theophylline
Generic theophylline
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "48bf9d36-1151-79d1-e063-6394a90aee09", "openfda": {"nui": ["N0000175790", "M0023046"], "upc": ["0342291922013"], "unii": ["0I55128JYK"], "rxcui": ["317769"], "spl_set_id": ["f93e20b1-97aa-088d-e053-6394a90a25d4"], "pharm_class_cs": ["Xanthines [CS]"], "pharm_class_epc": ["Methylxanthine [EPC]"], "manufacturer_name": ["AvKARE"]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (42291-922-01)", "package_ndc": "42291-922-01", "marketing_start_date": "20230413"}], "brand_name": "Theophylline", "product_id": "42291-922_48bf9d36-1151-79d1-e063-6394a90aee09", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Methylxanthine [EPC]", "Xanthines [CS]"], "product_ndc": "42291-922", "generic_name": "Theophylline", "labeler_name": "AvKARE", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Theophylline", "active_ingredients": [{"name": "THEOPHYLLINE ANHYDROUS", "strength": "300 mg/1"}], "application_number": "ANDA089763", "marketing_category": "ANDA", "marketing_start_date": "20230413", "listing_expiration_date": "20271231"}